
News|Articles|October 7, 2025
Pharmacist Takeover: BCMA Bispecifics and CAR T-Cell Therapy
Author(s)Alexandra Gerlach, Associate Editor
Key Takeaways
- Personalized treatment strategies have become central to managing lung cancer brain metastases, improving patient outcomes.
- Targeted therapies and immunotherapies offer more effective, less invasive options compared to traditional methods.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Higher Ultra-Processed Food Intake Linked to Increased Prediabetes Risk in Young Adults
3
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
4
The Dual Burden of CAR T-Cell Therapy: Financial and Time Toxicity in the Era of Precision Oncology
5


















































































































































































































